1.
Clin Infect Dis
; 64(9): 1275-1278, 2017 05 01.
Article
in English
| MEDLINE
| ID: mdl-28199492
ABSTRACT
We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.